Tscan Therapeutics Inc (TCRX) Stock Price, Quote & News

Company Profile

TScan Therapeutics, Inc., a clinical-stage biotechnology company, develops T cell receptor-engineered T cell (TCR-T) therapies for the treatment of patients with cancer in the United States. The company's lead product is TSC-101, for the treatment of patients with acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), and acute lymphoblastic leukemia (ALL) in patients undergoing allogeneic hematopoietic cell transplantation (HCT), which is in Phase I clinical trial, as well as eliminates...

Industry: Biotechnology

Sector: Healthcare

Phone: 857 399 9500

Website: www.tscan.com

Address:

830 Winter Street, Waltham, United States

Mmmm1319 Aug. 3 at 7:27 PM

$TCRX Good, they should just delist this POS

0 · Reply

SQUEAKSBANDIT Aug. 3 at 5:34 PM

$TCRX approx 1 yr cash on hand we should soon see 1. a decent correction above a buck or 2. a sale of shares/warrants likely a lot of prefunds and the price crashes under .50

0 · Reply

SaladMan00 Aug. 3 at 4:17 PM

$TCRX keep adding at these prices. Have a proper stop limit

0 · Reply

Mmmm1319 Aug. 3 at 3:46 PM

$TCRX Good luck to yall

0 · Reply

Mmmm1319 Aug. 3 at 3:46 PM

$TCRX This stock sucks azz lol. Sold out everything

0 · Reply

zeustony88 Jul. 30 at 12:37 PM

$TCRX Adding shares today

0 · Reply

suredubb Jul. 29 at 10:41 PM

$TCRX just keep accumulating… tutes love these prices Baker Bros involved

0 · Reply

GeorgeJonesFan_In_Boston Jul. 28 at 9:04 PM

$TCRX

0 · Reply

JuggernautRaider Jul. 27 at 3:57 PM

$TCRX $TLSA $CGTX all look like screaming steals of deals at these low low prices… 🏦 $CTXR … my jury’s still out on… 🧐 what is Citius up to? 🧐

1 · Reply

GamblingFerret Jul. 26 at 1:24 PM

$TCRX https://clinicaltrials.gov/study/NCT07702578?term=Tscan&amp;viewType=Card&amp;lastUpdPost=2026-07-17_&amp;rank=1 Phase 3 running, but results not before 2029… With unclear financing, I stay at the sideline and join as soon as there is more transparency. Not need to rush based on given timeline, as risk for short term dilution is high (besides some kind of deal appears)

2 · Reply